AGP Executive Report
Last update: 10 hours agoPFAS Health Risks: A new CDC/ATSDR-linked study presented in Pennsylvania finds PFAS exposure near military bases is associated with higher blood pressure and cholesterol, plus lower childhood development. Massachusetts Policy & Health: Blue Cross Blue Shield of Massachusetts Foundation named Liz Sanchez to lead the Massachusetts Medicaid Policy Institute, aiming to track MassHealth changes and shape policy research. Cancer Immunology: Dana-Farber researchers report how p53 mutations can stay “invisible” to T cells, and propose a strategy to change what tumors display so the immune system can recognize them. Gene Therapy Milestone: Ultragenyx won full FDA approval for FAYUVI, the first approved treatment for Sanfilippo syndrome Type A. Boston Tech & Privacy: Boston ended its Flock Safety relationship after data-breach concerns, as other towns weigh whether to keep using AI-powered surveillance. AI in Education: Massachusetts students and libraries are pushing AI literacy and youth mental health supports, while a separate AI literacy initiative expands across 170+ private schools. Local STEM/Workforce: Boston College launched a remote work-study pilot for incarcerated men at MCI Shirley, paying them $25 an hour and training them on modern workplace skills. Campus Arts: Boston University faces backlash after planning to discontinue its MFA playwriting program. Cybersecurity & Business: Rapid7 granted inducement awards to new hires, underscoring continued growth in AI-powered cybersecurity operations.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.